ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Yifan Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1972-1150; OpenAlex author ID A5055701267. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Nomogram for prognosis prediction in metastatic pancreatic cancer patients undergoing intra-arterial infusion chemotherapy: incorporating immune-inflammation s… Co-author DOI 10.1186/s12885-025-13523-3 ↗
Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal aden… Co-author DOI 10.1038/s41392-024-02052-3 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yongqiang Hua · 1 shared paper, 2025 · strength 0.42
- Paper Nomogram for prognosis prediction in metastatic pancreatic cancer patients undergoing intra-arterial infusion chemother… DOI 10.1186/s12885-025-13523-3 ↗
Zhouyu Ning · 1 shared paper, 2024 · strength 0.18
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3 ↗
Lixia Yi · 1 shared paper, 2024 · strength 0.18
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3 ↗
Waimei Si · 1 shared paper, 2024 · strength 0.18
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3 ↗
Jing Xie · 1 shared paper, 2024 · strength 0.18
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3 ↗
Xiaoyan Zhu · 1 shared paper, 2024 · strength 0.18
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3 ↗
Zhiqiang Meng · 1 shared paper, 2024 · strength 0.18
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.